Australia Stock Exchange release from ONCOSIL MEDICAL : Half Yearly Report and Accounts
22/02/2022 05:36
Australia Stock Exchange release from ONCOSIL MEDICAL OSL.AX : Half Yearly Report and Accounts
Recent news on Oncosil Medical
See all newsAustralia's OncoSil Medical gains most in over 2 months on reaching 100-th patient milestone
Brief: Oncosil Medical Says FDA Grants Hde Approval For Oncosil Device For Distal Cholangiocarcinoma
Brief: Oncosil Medical Posts FY26 Unit Sales Up 53%, Revenue Up 44% Versus FY25
Brief: Oncosil Medical Receives Saudi FDA Approval
Brief: Oncosil Medical Files For FDA Approval